Rogosin Manhattan Dialysis Center — New York, New York

Rogosin Manhattan Dialysis Center is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rogosin Manhattan Dialysis Center has participated in 1 clinical trials.

Therapeutic areas: Fatigue, End Stage Renal Disease (ESRD).

Sponsors: Sepsicure.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rogosin Manhattan Dialysis Center?

Rogosin Manhattan Dialysis Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rogosin Manhattan Dialysis Center conducted?

Rogosin Manhattan Dialysis Center has 1 clinical trials on record. Their work covers Fatigue, End Stage Renal Disease (ESRD).

Is Rogosin Manhattan Dialysis Center accredited by Crixeo Health?

Rogosin Manhattan Dialysis Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rogosin Manhattan Dialysis Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.